ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AXSM Axsome Therapeutics Inc

71.52
0.00 (0.00%)
Apr 25 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Axsome Therapeutics Inc AXSM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 71.52 20:00:00
Open Price Low Price High Price Close Price Prev Close
71.52
more quote information »

Recent News

Date Time Source Heading
4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/15/202407:00GLOBEAxsome Therapeutics Highlights Innovative Neuroscience..
4/10/202407:00GLOBEAxsome Therapeutics to Report First Quarter 2024 Financial..
4/01/202407:00GLOBEAxsome Therapeutics Initiates ENGAGE Phase 3 Trial of..
3/25/202407:00GLOBEAxsome Therapeutics Announces Results of CRESCENDO..
3/25/202406:30GLOBEAxsome Therapeutics Announces AXS-12 Achieves Primary..
3/19/202407:00GLOBEAxsome Therapeutics Initiates PARADIGM Phase 3 Trial of..
3/05/202407:00GLOBEAxsome Therapeutics to Present at the Leerink Partners..
2/29/202418:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202418:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202417:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202407:00GLOBEAxsome Therapeutics to Present at the TD Cowen 44th Annual..
2/23/202408:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/20/202407:05EDGAR2Form 8-K - Current report
2/20/202407:00GLOBEAxsome Therapeutics Reports Fourth Quarter and Full Year..
2/20/202405:37IHMARKETNEWSMarket Cautiousness Ahead of Retail Giants’ Earnings; Oil..
2/14/202415:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/23/202407:00GLOBEAxsome Therapeutics to Report Fourth Quarter and Full Year..
1/08/202407:10EDGAR2Form 8-K - Current report
1/04/202407:11EDGAR2Form 8-K - Current report
1/04/202407:00GLOBEAxsome Therapeutics Provides Preliminary Fourth Quarter and..
12/11/202307:00GLOBEAxsome Therapeutics Presents New Data and Post-Hoc Analyses..
12/07/202316:05EDGAR2Form 8-K - Current report
12/07/202307:00GLOBEAxsome Therapeutics Hosts Solriamfetol Virtual Investor..
11/22/202307:00GLOBEAxsome Therapeutics to Host Solriamfetol Virtual Investor..
11/21/202307:00GLOBEAxsome Therapeutics to Present at the Piper Sandler 35th..
11/06/202316:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/06/202307:05EDGAR2Form 8-K - Current report
11/06/202307:00GLOBEAxsome Therapeutics Reports Third Quarter 2023 Financial..
11/06/202306:54IHMARKETNEWSMonday’s Wall Street Highlights: Berkshire Hathaway, Tesla,..
11/02/202307:00GLOBEAxsome Therapeutics and the Global Alzheimer’s Disease..
10/31/202307:00GLOBEAxsome Therapeutics to Present at Upcoming Investor..
10/24/202307:00GLOBEAxsome Therapeutics Presents Results of the ACCORD trial of..
10/11/202317:03EDGAR2Form 8-K - Current report
10/11/202307:00GLOBEAxsome Therapeutics Appoints Dr. Sue Mahony to its Board of..
10/10/202307:00GLOBEAxsome Therapeutics to Report Third Quarter 2023 Financial..
10/02/202307:00GLOBEAxsome Therapeutics Joins the National Alliance on Mental..
9/21/202307:00GLOBEAxsome Therapeutics Joins the Global Narcolepsy Community in..
9/15/202318:32EDGAR2Form 144 - Report of proposed sale of securities
9/15/202318:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/07/202307:03GLOBEAxsome Therapeutics Highlights Commitment to Innovating..
9/05/202307:00GLOBEAxsome Therapeutics to Present at Three Upcoming Investor..
8/15/202307:45EDGAR2Form 8-K - Current report
8/07/202317:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202316:02EDGAR2Form 8-K - Current report
8/07/202307:00GLOBEAxsome Therapeutics Reports Second Quarter 2023 Financial..
8/04/202316:49EDGAR2Form 8-K - Current report
7/12/202307:00GLOBEAxsome Therapeutics to Report Second Quarter 2023 Financial..
7/07/202316:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
7/07/202308:21EDGAR2Form 8-K - Current report
7/07/202307:00GLOBEAxsome Therapeutics Initiates FOCUS Phase 3 Trial of..

Your Recent History

Delayed Upgrade Clock